# Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

> **NCT03588494** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Affiliated Hospital of North Sichuan Medical College** · enrollment: 318 (estimated)

## Conditions studied

- Quality of Life

## Interventions

- **COMBINATION_PRODUCT:** concurrent chemoradiotherapy (CCRT)
- **DRUG:** Endostar for one cycle
- **DRUG:** Endostar for two cycles

## Key facts

- **NCT ID:** NCT03588494
- **Lead sponsor:** Affiliated Hospital of North Sichuan Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 318 (ESTIMATED)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03588494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03588494, "Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03588494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*